Epigenetic reprogramming enables NF1A/B oncogenic role in SHH medulloblastoma
Developmental Cell · 2024
DOI: 10.1016/j.devcel.2024.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2024. Verfasst von Sara Badodi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumour Research Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: …. Hauptthemen laut MEDLINE: Medulloblastoma, Epigenesis, Genetic, Hedgehog Proteins, NFI Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brain Tumour Research Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: s.badodi@qmul.ac.uk.
- Brain Tumour Research Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK; Barts Brain Tumour Centre, Faculty of Medicine and Dentistry, Queen Mary University of Lon…
Zitieren
APA
Badodi, S., & Marino, S. (2024). Epigenetic reprogramming enables NF1A/B oncogenic role in SHH medulloblastoma. Developmental Cell. https://doi.org/10.1016/j.devcel.2024.07.002
Vancouver
Badodi S, Marino S. Epigenetic reprogramming enables NF1A/B oncogenic role in SHH medulloblastoma. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.07.002
BibTeX
@article{Badodi2024,
author = {Badodi, Sara and Marino, Silvia},
title = {Epigenetic reprogramming enables NF1A/B oncogenic role in SHH medulloblastoma},
journal = {Developmental Cell},
year = {2024},
doi = {10.1016/j.devcel.2024.07.002}
}
EUVIMED